www.fdanews.com/articles/177062-terumo-to-buy-sequent-medical
Japanese devicemaker Terumo has acquired Sequent Medical, a developer of intrasaccular flow disrupters, in a transaction worth $280 million with up to $100 million more in potential milestone payments.
The transaction is expected to close in July or August of this year. — Anisa Jibrell